Investors Economics Commentary Forex Politics Entertainment Content Sales Search   Advanced Search
LATEST NEWS
 
 
FREE Email Alerts
Free Content 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Health News
 Earnings News
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 Slide Shows
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 All Genres
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
 DVD Calendar
 Movie Calendar
 Concert Calendar
 Album Calendar
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Active Traders
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
 Growth and Value Stocks
 RTT NewsStream
Economic Calendar
RTT DeskAlert
Mobile

Follow Us
RTTNews on Twitter RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube

Add to Google

Gilead Sciences Inc(GILD)

Trade GILD now with

RTTNews Articles

Gilead Sciences Furnishes Update On $5.0 Bln Stock Buyback Program - Quick Facts
9/1/2010 8:44:13 AM     RTT News
Gilead Sciences Issues Update On $5 Bln Stock Buyback
9/1/2010 8:35:48 AM     RTT News
Gilead Sciences Notified Of ANDA Filing For Hepsera - Quick Facts
8/19/2010 8:07:12 PM     RTT News
Gilead Sciences Announces Notification Of ANDA Filing For Hepsera
8/19/2010 8:01:14 PM     RTT News
Deutsche Bank Starts Gilead Sciences Inc (GILD) At Buy With $42 Price Target
8/16/2010 5:06:32 PM     RTT News
Gilead Sciences Closes Sale Of $2.2 Bln Of Convertible Senior Notes
7/30/2010 4:53:02 PM     RTT News
Gilead Sciences Closes Sale Of $2.2 Bln Of Convertible Senior Notes
7/30/2010 4:32:38 PM     RTT News
Gilead Sciences Prices $2.2 Bln Of Convertible Senior Notes - Quick Facts
7/27/2010 8:43:21 AM     RTT News
Gilead Sciences Prices $2.2 Bln Of Convertible Senior Notes
7/27/2010 8:31:41 AM     RTT News
Tibotec Pharma Submits NDA To FDA For Investigational Once-Daily HIV Treatment TMC278 - Quick Facts
7/26/2010 8:38:37 AM     RTT News
Tibotec Pharmaceuticals Submits NDA For Investigational Once-Daily HIV Treatment TMC278 To FDA
7/26/2010 8:32:16 AM     RTT News
Gilead Sciences To Offer $2.2 Bln Of Convertible Senior Notes; To Buy Back $1 Bln In Common Stock - Quick Facts
7/26/2010 7:28:31 AM     RTT News
Gilead Sciences To Offer $2.2 Bln Of Convertible Senior Notes
7/26/2010 7:07:44 AM     RTT News
Tibotec Pharma Says TMC278 Pivotal Phase 3 Clinical Trials Achieve Primary Objective - Quick Facts
7/22/2010 9:07:53 AM     RTT News
TMC278 Pivotal Phase 3 Clinical Trials Achieve Primary Objective
7/22/2010 8:41:16 AM     RTT News
Gilead Sciences Q2 Profit Rises, But Miss Estimates
7/20/2010 6:52:37 PM     RTT News
Gilead Sciences Inc. Is Down On Q2 Earnings News
7/20/2010 4:58:16 PM     RTT News
Gilead Sciences Q2 Profit Rises - Quick Facts
7/20/2010 4:23:01 PM     RTT News
Gilead Sciences Q2 Non-GAAP EPS Rises 22% To $0.85 From $0.69 Last Year
7/20/2010 4:07:54 PM     RTT News
Gilead Sciences Q2 10 Earnings Conference Call At 5:00 PM ET
7/20/2010 2:59:35 PM     RTT News
 
Previous 20 Headlines
  
 
 

Copyright © 2010 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback | Terms of Service | Advertise | Privacy | Buy Content | RSS | Mobile